UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that inhibiting the enzyme CARM1 (also called PRMT4) dramatically slows acute myeloid leukemia (AML) progression but does not affect normal blood production.

Full Story

Related posts

FSU: Volcanic activity, declining ocean oxygen triggered mass extinction of ancient marine organisms

Global climate change, fueled by skyrocketing levels of atmospheric carbon dioxide, is siphoning oxygen from…

USF Doctor examines how access to social services reduces health care costs

Study finds connecting patients with social services to address social determinants of health generates double-digit…

FIT Metals Solidification Theory A Hit In Prestigious Journal

A research discovery led by Florida Tech’s Martin Glicksman is making an impact in the metals world. Full Story